Myasthenia gravis is a chronic autoimmune neuromuscular disorder that affects voluntary muscles, leading to weakness and fatigue. In this condition, the immune system mistakenly targets and attacks the communication between nerves and muscles, impairing the normal functioning of muscles. Common symptoms include muscle weakness, especially in the face, neck, and extremities, as well as difficulties with activities like talking, swallowing, and breathing. The severity of symptoms can vary, and they may worsen with physical activity but improve with rest. Myasthenia gravis is typically managed with medications, such as acetylcholinesterase inhibitors, immunosuppressants, and sometimes thymectomy. While there is no cure, treatment can help alleviate symptoms and improve the quality of life for individuals with this condition.
Patients are the experts in their condition and advocacy groups provide a platform for patient voices. Working directly with these communities is the key to pushing research forward in an inclusive way.
Myasthenia gravis (MG) is a neuromuscular disorder characterized by muscle weakness and fatigue. Learn more about MG symptoms, methods to receive a diagnosis, and possible treatments to reduce severity of symptoms.
Read more...
We’ve committed to having 500,000 conversations in the next three years, to equip ourselves and our Pharma partners with the insights needed to increase predictability.
Read more...
The ever-growing investment in advocacy doesn’t appear to be slowing down, and research is certainly seeing the benefits. Which at the end of the day, means better patient care and more options for patients.
Read more...
We’re ready to keep forming links between our Advocacy friends and Pharma partners, so these fruitful relationships continue to evolve beyond the study-to-study view.
Read more...